Federated Hermes’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Federated Hermes’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-442	Closed	-$24K	–	2297
2016 Q1	$24K	Sell	442 -13,737	-97%	-$1.01M	﹤0.01%	1724
2015 Q4	$1.6M	Sell	14,179 -3,340	-19%	-$368K	0.01%	964
2015 Q3	$2.06M	Sell	17,519 -11,496	-40%	-$1.5M	0.01%	841
2015 Q2	$2.25M	Sell	29,015 -12,666	-30%	-$830K	0.01%	892
2015 Q1	$2.41M	Buy	+41,681	New	+$1.77M	0.01%	893

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Federated Hermes's ANAC Position: Q2 2016 in Review

Federated Hermes sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 442 shares — an estimated $24K sold.

Federated Hermes first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $2.41M in Q1 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Federated Hermes reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Federated Hermes sold 442 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $24K.
Federated Hermes first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Federated Hermes's ANACOR PHARMACEUTICALS INC COM position peaked at $2.41M in Q1 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Federated Hermes's 13F filing for Q2 2016, filed 12 Aug 2016.